These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11515549)

  • 21. In vitro selection of a purine nucleotide-specific hammerheadlike ribozyme.
    Vaish NK; Heaton PA; Fedorova O; Eckstein F
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2158-62. PubMed ID: 9482855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selecting allosteric ribozymes.
    Piganeau N
    Methods Mol Biol; 2012; 848():317-28. PubMed ID: 22315077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection of targets and the most efficient hairpin ribozymes for inactivation of mRNAs using a self-cleaving RNA library.
    Barroso-DelJesus A; Berzal-Herranz A
    EMBO Rep; 2001 Dec; 2(12):1112-8. PubMed ID: 11743025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A computational approach to predict suitable target sites for trans-acting minimal hammerhead ribozymes.
    Mercatanti A; Lande C; Citti L
    Methods Mol Biol; 2012; 848():337-56. PubMed ID: 22315079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A ribozyme that ligates RNA to protein.
    Baskerville S; Bartel DP
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9154-9. PubMed ID: 12077317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ribozymes: from mechanistic studies to applications in vivo.
    Ohkawa J; Koguma T; Kohda T; Taira K
    J Biochem; 1995 Aug; 118(2):251-8. PubMed ID: 8543555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cleavage of full-length beta APP mRNA by hammerhead ribozymes.
    Denman RB
    Nucleic Acids Res; 1993 Aug; 21(17):4119-25. PubMed ID: 8371986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro evolution suggests multiple origins for the hammerhead ribozyme.
    Salehi-Ashtiani K; Szostak JW
    Nature; 2001 Nov; 414(6859):82-4. PubMed ID: 11689947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro selection of allosteric ribozymes: theory and experimental validation.
    Piganeau N; Thuillier V; Famulok M
    J Mol Biol; 2001 Oct; 312(5):1177-90. PubMed ID: 11580234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.
    Bramlage B; Luzi E; Eckstein F
    Nucleic Acids Res; 2000 Nov; 28(21):4059-67. PubMed ID: 11058100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of the hairpin ribozyme derived from the negative strand of arabis mosaic virus satellite RNA.
    Hisamatsu S; Morikawa Y; Tomita R; Tanaka T; Sonoki S; Kikuchi Y
    J Biochem; 1997 Aug; 122(2):352-7. PubMed ID: 9378713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computer-Aided Design of Active Pseudoknotted Hammerhead Ribozymes.
    Najeh S; Zandi K; Djerroud S; Kharma N; Perreault J
    Methods Mol Biol; 2021; 2167():91-111. PubMed ID: 32712917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of ribozyme activity with short oligonucleotides.
    Komatsu Y
    Biol Pharm Bull; 2004 Apr; 27(4):457-62. PubMed ID: 15056847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimized hammerhead ribozymes.
    McCall MJ; Hendry P; Lockett TJ
    Methods Mol Biol; 1997; 74():151-9. PubMed ID: 9204430
    [No Abstract]   [Full Text] [Related]  

  • 36. Intracellular ribozyme-catalyzed trans-cleavage of RNA monitored by fluorescence resonance energy transfer.
    Vitiello D; Pecchia DB; Burke JM
    RNA; 2000 Apr; 6(4):628-37. PubMed ID: 10786853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An experimental method for selecting effective target sites and designing hairpin ribozymes.
    Barroso-delJesus A; Puerta-Fernández E; Romero-López C; Berzal-Herranz A
    Methods Mol Biol; 2004; 252():313-25. PubMed ID: 15017060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of hairpin ribozyme variants with improved activity for poorly processed substrates.
    Drude I; Strahl A; Galla D; Müller O; Müller S
    FEBS J; 2011 Feb; 278(4):622-33. PubMed ID: 21199369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catalytic strategies of self-cleaving ribozymes.
    Cochrane JC; Strobel SA
    Acc Chem Res; 2008 Aug; 41(8):1027-35. PubMed ID: 18652494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.
    Sun LQ; Wang L; Gerlach WL; Symonds G
    Nucleic Acids Res; 1995 Aug; 23(15):2909-13. PubMed ID: 7544887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.